Abelson Helper Integration Site 1 (AHI1) (C-Term) Peptid
Kurzübersicht für Abelson Helper Integration Site 1 (AHI1) (C-Term) Peptid (ABIN8093731)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- C-Term
-
Verwendungszweck
- Ahi1 Peptide - C-terminal region
-
Sequenz
- KDSTLRIMDL RILAARKFVG AANYREKIHS TLTPCGTLLF SGSEDGIVYV
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-Ahi1 Antibody (ARP56992_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- AHI1 (Abelson Helper Integration Site 1 (AHI1))
-
Hintergrund
-
Background Information: Mutations in the human homolog are associated with Joubert syndrome, an autosomal recessive disorder resulting in severe mental retardation.
Alternative Symbols: Ahi-1, Ahi1
-
Molekulargewicht
- 120kDa
-
Gen-ID
- 308923
-
NCBI Accession
- NP_001002277
-
UniProt
- Q6DTM3
Target
-